Polimedica Centrum Badan Profilaktyki I Leczenia Sp. z o.o.
- Address
- Aleja Komisji Edukacji Narodowej 98/u17, 02-777 Warsaw, Poland
Polimedica Centrum Badan Profilaktyki I Leczenia Sp. z o.o.
Polimedica Centrum Badan Profilaktyki I Leczenia is a comprehensive clinical research center specializing in preventive medicine and therapeutic interventions across diverse medical specialties. The center demonstrates expertise in conducting multi-phase clinical trials, from early-stage drug development to large-scale multicenter studies, with particular focus on chronic disease management and prevention strategies.
- Cardiovascular disease prevention and hyperuricemia management in high-risk patient populations, including post-COVID cardiovascular complications
- Allergic disorders including house dust mite-induced rhinitis, rhinoconjunctivitis, and asthma, utilizing advanced immunotherapy approaches
- Endocrine and autoimmune conditions, specifically thyroid eye disease and related ophthalmologic manifestations
The research center's portfolio reflects a commitment to addressing complex, multi-system conditions affecting quality of life. Their work encompasses cardiovascular risk stratification in patients with metabolic disorders, subcutaneous immunotherapy for respiratory allergies, and novel biological therapies for chronic thyroid eye disease. The center's experience with placebo-controlled, double-blind study designs demonstrates rigorous scientific methodology in evaluating both preventive interventions and therapeutic agents across multiple disease states, including conditions complicated by long-COVID syndrome.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 34 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Agencja Badań Medycznych1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Polimedica Centrum Badan Profilaktyki I Leczenia Sp. z o.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Dose-finding study of polymerized grass pollen extract in patients with allergic rhinoconjunctivitis with or without asthma | Probelte Pharma S.L. | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 34 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Agrostis Stolonifera Pollen | 1 | Unknown | 2024-08-22 | 2024-08-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.